Literature DB >> 17623394

Dimensionality and the category of major depressive episode.

Gavin Andrews1, Traolach Brugha, Michael E Thase, Farifteh Firoozmand Duffy, Paola Rucci, Timothy Slade.   

Abstract

Major depressive episode (MDE) is a chronic disease typified by episodes that remit and recur. It is a major contributor to the burden of disease. The diagnosis of a disorder is an expert opinion that the disorder is present. The nine symptoms of MDE exist on dimensions of greater or lesser intensity, persistence over time, change in usual state, distress and impairment. It is the clinician's task to judge whether the elicited symptoms warrant the diagnosis. The surprise is that trained clinicians can do this reliably and that diagnostic interviews and questionnaires can emulate this process. The distribution of symptoms in community surveys is exponential, with no obvious discontinuity at the diagnostic threshold. Taxometric and primary care studies confirm this. The number of symptoms predicts severity, comorbidity, family history, disability, help seeking and treatment recommendations. The latent structure of mental disorders places MDE in the distress misery cluster. Measures of well-being, distress, disability and neuroticism correlate with the number of symptoms but the relation is not perfect. The Patient Health Questionnaire is derived from the diagnostic criteria and does not suffer this limitation. The introduction of measures like this would acknowledge dimensionality, would facilitate recognition, guide treatment, and be acceptable to consumers, providers and funders. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17623394      PMCID: PMC6879076          DOI: 10.1002/mpr.216

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  27 in total

1.  Lifetime risk of depression: restricted to a minority or waiting for most?

Authors:  Gavin Andrews; Richie Poulton; Ingmar Skoog
Journal:  Br J Psychiatry       Date:  2005-12       Impact factor: 9.319

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

4.  Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey.

Authors:  G Andrews; S Henderson; W Hall
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

5.  Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal.

Authors:  T A Brown; B F Chorpita; D H Barlow
Journal:  J Abnorm Psychol       Date:  1998-05

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  1998-08

8.  Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being.

Authors:  Gavin Andrews; Tim Slade; Cathy Issakidis
Journal:  Br J Psychiatry       Date:  2002-10       Impact factor: 9.319

9.  Global burden of depressive disorders in the year 2000.

Authors:  T B Ustün; J L Ayuso-Mateos; S Chatterji; C Mathers; C J L Murray
Journal:  Br J Psychiatry       Date:  2004-05       Impact factor: 9.319

10.  The long-term outcome of Maudsley depressives.

Authors:  A S Lee; R M Murray
Journal:  Br J Psychiatry       Date:  1988-12       Impact factor: 9.319

View more
  21 in total

1.  Toward Robust Anxiety Biomarkers: A Machine Learning Approach in a Large-Scale Sample.

Authors:  Emily A Boeke; Avram J Holmes; Elizabeth A Phelps
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-06-21

2.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-14       Impact factor: 5.270

3.  Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia.

Authors:  Vilma Gabbay; Xiangling Mao; Rachel G Klein; Benjamin A Ely; James S Babb; Aviva M Panzer; Carmen M Alonso; Dikoma C Shungu
Journal:  Arch Gen Psychiatry       Date:  2011-10-03

Review 4.  DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder.

Authors:  James M Swanson; Timothy Wigal; Kimberley Lakes
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

5.  Heritability of depressive symptoms: a case study using a multilevel approach.

Authors:  Amy L Byers; Becca R Levy; Stanislav V Kasl; Martha L Bruce; Heather G Allore
Journal:  Int J Methods Psychiatr Res       Date:  2009-12       Impact factor: 4.035

6.  The Power of Theory, Research Design, and Transdisciplinary Integration in Moving Psychopathology Forward.

Authors:  Uma Vaidyanathan; Scott I Vrieze; William G Iacono
Journal:  Psychol Inq       Date:  2015-08-28

7.  A dimensional versus a categorical approach to diagnosis: anxiety and depression in the HUNT 2 study.

Authors:  Ingvar Bjelland; Stein A Lie; Alv A Dahl; Arnstein Mykletun; Eystein Stordal; Helena C Kraemer
Journal:  Int J Methods Psychiatr Res       Date:  2009-06       Impact factor: 4.035

8.  Classification of depressive disorders in the DSM-V: proposal for a two-dimension system.

Authors:  Daniel N Klein
Journal:  J Abnorm Psychol       Date:  2008-08

9.  In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder.

Authors:  Kyle A B Lapidus; Vilma Gabbay; Xiangling Mao; Amy Johnson; James W Murrough; Sanjay J Mathew; Dikoma C Shungu
Journal:  Neurosci Lett       Date:  2014-04-02       Impact factor: 3.046

10.  Course of depression in a 10-year prospective study: Evidence for qualitatively distinct subgroups.

Authors:  Daniel N Klein; Roman Kotov
Journal:  J Abnorm Psychol       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.